See on Scoop.it - Alzheimer's and Dementia
A failed Alzheimer's trial is pressuring the drug and medical-device company's stock, but we expect shares to recover.
See on online.barrons.com
A failed Alzheimer's trial is pressuring the drug and medical-device company's stock, but we expect shares to recover.
No comments:
Post a Comment